IPSC - Century Therapeutics Inc
IEX Last Trade
1.76
0.030 1.705%
Share volume: 373,313
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.73
0.03
1.73%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-11 | 2022-11-10 | 2023-03-16 | 2023-05-11 | 2023-08-09 | 2023-11-09 | 2024-03-14 | 2024-05-09 | |
| Assets | |||||||||
| Total Assets | 532.584 M | 511.751 M | 486.544 M | 456.228 M | 417.159 M | 397.551 M | 360.691 M | 348.507 M | |
| Current Assets | 383.793 M | 361.641 M | 319.721 M | 255.934 M | 161.280 M | 173.703 M | 176.994 M | 199.813 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 4.564 M | 5.436 M | 4.003 M | 4.465 M | 4.883 M | 4.198 M | 4.256 M | 7.797 M | |
| Short Term Investments | 4.564 M | 5.436 M | 4.003 M | 4.465 M | 4.883 M | 4.198 M | 4.256 M | 7.797 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 378.758 M | 355.859 M | 315.498 M | 251.469 M | 156.397 M | 169.505 M | 172.738 M | 192.016 M | |
| Total Non-current Assets | 148.791 M | 150.110 M | 166.823 M | 200.294 M | 255.879 M | 223.848 M | 183.697 M | 148.694 M | |
| Property Plant Equipment | 69.971 M | 77.938 M | 82.785 M | 85.842 M | 83.771 M | 81.993 M | 71.705 M | 69.005 M | |
| Other Assets | 26.234 M | 30.766 M | 30.205 M | 29.157 M | 25.548 M | 25.114 M | 20.917 M | 19.858 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 532.584 M | 511.751 M | 486.544 M | 456.228 M | 417.159 M | 397.551 M | 360.691 M | 348.507 M | |
| Total liabilities | 174.632 M | 181.546 M | 183.806 M | 179.053 M | 169.588 M | 178.321 M | 175.941 M | 170.624 M | |
| Total current liabilities | 21.569 M | 26.907 M | 29.817 M | 27.684 M | 19.161 M | 20.435 M | 17.846 M | 16.065 M | |
| Accounts Payable | 4.048 M | 5.685 M | 5.454 M | 3.475 M | 3.625 M | 5.927 M | 2.741 M | 3.432 M | |
| Other liabilities | 114.129 M | 111.909 M | 111.552 M | 110.201 M | 109.594 M | 112.351 M | 111.437 M | 110.308 M | |
| Current long term debt | 1.594 M | 4.036 M | 6.502 M | 10.297 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 38.934 M | 42.730 M | 42.437 M | 41.168 M | 40.833 M | 45.535 M | 46.658 M | 44.251 M | |
| Other liabilities | 114.129 M | 111.909 M | 111.552 M | 110.201 M | 109.594 M | 112.351 M | 111.437 M | 110.308 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 357.952 M | 330.205 M | 302.738 M | 277.175 M | 247.571 M | 219.230 M | 184.750 M | 177.883 M | |
| Common stock | 57.685 M | 57.974 M | 58.313 M | 58.610 M | 59.251 M | 59.448 M | 53.713 M | 62.297 M | |
| Retained earnings | -456.667 M | -487.416 M | -519.098 M | -550.362 M | -583.652 M | -616.373 M | -655.771 M | -683.833 M |